Eris Lifesciences Limited has informed the Exchange regarding Allotment of 12293 Shares.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has allotted 12,293 equity shares to employees who exercised options under the ESOP-2021 Scheme on June 5, 2025. The shares were granted across three years: 4,061 shares (2022 grant) at Rs. 557.24, 5,020 shares (2023 grant) at Rs. 510.32, and 3,212 shares (2024 grant) at Rs. 728.16 per share. As a result, the company's paid-up share capital increased from Rs. 13,61,85,032 to Rs. 13,61,97,325 (equity shares of Re. 1 each). The dilution impact is very minor at roughly 0.009% of total share capital.
This is a routine ESOP allotment with negligible dilution; no material impact on share price or shareholder value is expected.